License-In
Summaries of 2 newly published patent applications are added to "Patent Portfolio"
We released the summaries of 2 newly published patent applications from our "Patent Portfolio" as follows. AJ141 Compound for removing huma...
License-In
We released the summaries of 2 newly published patent applications from our "Patent Portfolio" as follows. AJ141 Compound for removing huma...
results 141 - 150 of 231
Other
New patent information relates to iPS cell technologies for the month of February 2018 has been updated. Please see Patent Information for m...
License-Out
We executed a non-exclusive license agreement with Platelet Biogenesis, Inc. (Cambridge, U.S.A.) for the use of iPS cell-derived platelet pr...
License-In
We have executed an exclusive license-in agreement with Kwansei Gakuin University as to their invention under a patent entitled “Method for ...
Other
New patent information relates to iPS cell technologies for the month of January 2018 has been updated. Please see Patent Information for mo...
License-Out
We executed a non-exclusive license agreement with Stemnovate Ltd. which provides services related to iPS cells for research use, on the pat...
License-In
We released the summaries of 4 newly published patent applications from our "Patent Portfolio" as follows. AJ146 Method for producing CD4/C...
License-Out
We have executed a non-exclusive license agreement with Elpis Biomed Limited, under which Elpis generates iPS cell-derived, differentiated h...
Other
New patent information relates to iPS cell technologies for the month of December 2017 has been updated. Please see Patent Information for m...
License-Out
iPS Academia Japan, Inc.: We executed a non-exclusive license agreement with myriamed GmbH, Germany which provides services in drug developm...